1. Home
  2. EVEX vs RCUS Comparison

EVEX vs RCUS Comparison

Compare EVEX & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVEX
  • RCUS
  • Stock Information
  • Founded
  • EVEX 2020
  • RCUS 2015
  • Country
  • EVEX United States
  • RCUS United States
  • Employees
  • EVEX N/A
  • RCUS N/A
  • Industry
  • EVEX Aerospace
  • RCUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • EVEX Industrials
  • RCUS Health Care
  • Exchange
  • EVEX Nasdaq
  • RCUS Nasdaq
  • Market Cap
  • EVEX 1.3B
  • RCUS 1.2B
  • IPO Year
  • EVEX N/A
  • RCUS 2018
  • Fundamental
  • Price
  • EVEX $4.18
  • RCUS $11.07
  • Analyst Decision
  • EVEX Strong Buy
  • RCUS Buy
  • Analyst Count
  • EVEX 3
  • RCUS 11
  • Target Price
  • EVEX $6.00
  • RCUS $31.11
  • AVG Volume (30 Days)
  • EVEX 197.9K
  • RCUS 1.1M
  • Earning Date
  • EVEX 03-07-2025
  • RCUS 02-25-2025
  • Dividend Yield
  • EVEX N/A
  • RCUS N/A
  • EPS Growth
  • EVEX N/A
  • RCUS N/A
  • EPS
  • EVEX N/A
  • RCUS N/A
  • Revenue
  • EVEX N/A
  • RCUS $263,000,000.00
  • Revenue This Year
  • EVEX N/A
  • RCUS $127.65
  • Revenue Next Year
  • EVEX N/A
  • RCUS N/A
  • P/E Ratio
  • EVEX N/A
  • RCUS N/A
  • Revenue Growth
  • EVEX N/A
  • RCUS 119.17
  • 52 Week Low
  • EVEX $2.33
  • RCUS $10.63
  • 52 Week High
  • EVEX $6.09
  • RCUS $20.31
  • Technical
  • Relative Strength Index (RSI)
  • EVEX 39.23
  • RCUS 34.34
  • Support Level
  • EVEX $4.36
  • RCUS $10.63
  • Resistance Level
  • EVEX $5.04
  • RCUS $13.49
  • Average True Range (ATR)
  • EVEX 0.29
  • RCUS 0.77
  • MACD
  • EVEX -0.05
  • RCUS -0.13
  • Stochastic Oscillator
  • EVEX 0.58
  • RCUS 13.88

About EVEX Eve Holding Inc.

Eve Holding Inc is a provider of Urban Air Mobility solutions. The company's operating segments are; eVTOL that includes; the design and production of electric vertical take-off and landing vehicles (eVTOLs) including fixed wing and helicopter operators, as well as lessors that purchase and manage aircraft on behalf of operators; Service and Operations Solutions segment which includes a portfolio of maintenance and support services focused on its and third-party eVTOLs; and the UATM segment , a new Urban Air Traffic Management system designed to allow eVTOLs to operate safely and efficiently in dense urban airspace alongside conventional aircraft and drones.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: